A multi-centre stereotactic radiosurgery planning study of multiple brain metastases using isocentric linear accelerators with 5 and 2.5 mm width multi-leaf collimators, CyberKnife and Gamma Knife.
brain
metastases
multi-leaf collimator
stereotactic radiosurgery
Journal
BJR open
ISSN: 2513-9878
Titre abrégé: BJR Open
Pays: England
ID NLM: 101749810
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
15
02
2024
revised:
15
02
2024
accepted:
15
02
2024
medline:
19
2
2024
pubmed:
19
2
2024
entrez:
19
2
2024
Statut:
epublish
Résumé
This study compared plans of high definition (HD), 2.5 mm width multi-leaf collimator (MLC), to standard, 5 mm width, isocentric linear accelerator (linacs), CyberKnife (CK), and Gamma Knife (GK) for stereotactic radiosurgery (SRS) techniques on multiple brain metastases. Eleven patients undergoing SRS for multiple brain metastases were chosen. Targets and organs at risk (OARs) were delineated and optimized SRS plans were generated and compared. The linacs delivered similar conformity index (CI) values, but the gradient index (GI) for HD MLCs was significantly lower ( Comparing linacs for SRS, the preferred choice is HD MLCs. Similar results were achieved with the HD MLC linac, CK, or GK, with each delivering significant improvements in different aspects of plan quality. This article is the first to compare HD and standard width MLC linac plans using a combination of single isocentre volumetric modulated arc therapy and multi-isocentric dynamic conformal arc plans as required, which is a more clinically relevant assessment. Furthermore, it compares these plans with CK and GK, assessing the relative merits of each technique.
Identifiants
pubmed: 38371494
doi: 10.1093/bjro/tzae003
pii: tzae003
pmc: PMC10873585
doi:
Types de publication
Journal Article
Langues
eng
Pagination
tzae003Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Institute of Radiology.
Déclaration de conflit d'intérêts
There are no conflicts of interest to declare.